Endocyte Inc. buy melinda
Start price
07.10.17
/
50%
€5.06
Target price
27.12.17
€5.41
Performance (%)
-21.03%
End price
27.12.17
€4.00
Summary
This prediction ended on 27.12.17 with a price of €4.00. The prediction for Endocyte Inc. disappointed with a performance of -21.03%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Endocyte Inc. | - | - | - | - |
| iShares Core DAX® | 0.060% | 1.215% | 18.128% | 70.406% |
| iShares Nasdaq 100 | -3.065% | -0.519% | 2.080% | 103.787% |
| iShares Nikkei 225® | -2.094% | -3.066% | 11.655% | 45.417% |
| iShares S&P 500 | -1.657% | -0.069% | 1.103% | 64.908% |
Comments by melinda for this prediction
In the thread Endocyte Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
(Vom Mitglied beendet)